Beta-containing COVID-19 booster vaccine found to cross-neutralize

A new paper presents preliminary evidence that a new vaccine candidate, designed to boost immunity in already immunized individuals, and containing the adjuvanted Beta spike variant protein antigen, can induce a potent cross-neutralizing antibody response in non-human primate models that is detectable for up to three months.

Peptide Products for SARS-CoV-2

Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization - ScienceDirect

SARS-CoV-2 Omicron variant - Wikipedia

Neutralization potency of COVID-19 vaccine boosters against SARS

Vaccines, Free Full-Text

Sinopharm BIBP COVID-19 vaccine - Wikipedia

Study shows fully vaccinated individuals preserve cross-neutralizing memory B-cells against SARS-CoV-2 Omicron variant

Moderna Says Studies Show Its Vaccine Is Effective Against The Delta Variant

Moderna COVID-19 vaccine - Wikipedia

Novavax on X: NEWS: Novavax Announces #COVID19 Vaccine Booster Data Demonstrating Four-Fold Increase in Neutralizing Antibody Levels Versus Peak Responses After Primary Vaccination / X

COVID-19 booster after Omicron: Are 3rd or 4th shots necessary?

Vitamins, microelements and the immune system: current standpoint in the fight against coronavirus disease 2019, British Journal of Nutrition

mutI-tri-RBD induced significantly higher titer of neutralizing

From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era - ScienceDirect